Piotr Rhone Selected Research

Piotr Rhone Research Topics

14	Breast Neoplasms (Breast Cancer) 03/2024 - 07/2010
6	Neoplasms (Cancer) 03/2024 - 04/2015
1	Venous Thromboembolism 04/2023
1	Thrombophilia 04/2023
1	Lymphatic Metastasis 04/2022
1	Unilateral Breast Neoplasms 05/2021
1	Overweight 05/2021
1	Disease Progression 06/2020
1	Obesity 06/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Wilms Tumor (Wilm's Tumor) 01/2020
1	Lobular Carcinoma 01/2018
1	Ductal Carcinoma 01/2018
1	Pain (Aches) 04/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2013

5	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2019
4	AntigensIBA 04/2023 - 07/2013
3	Phenobarbital (Luminal)FDA Link 03/2024 - 12/2022
3	AdiponectinIBA 08/2023 - 06/2020
3	LeptinIBA 08/2023 - 06/2020
3	Plasminogen Activator Inhibitor 1IBA 04/2023 - 01/2018
2	von Willebrand FactorIBA 08/2023 - 01/2020
2	SelectinsIBA 08/2023 - 01/2020
2	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2023 - 04/2022
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 04/2023 - 01/2018
2	Thromboplastin (Tissue Factor)IBA 04/2023 - 06/2020
2	Plasminogen Activators (Plasminogen Activator)IBA 04/2023 - 04/2022
2	Indicators and Reagents (Reagents)IBA 04/2022 - 01/2020
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2021 - 09/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021 - 09/2019
1	Advanced Oxidation Protein Products (AOPP)IBA 03/2024
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2022
1	Plasminogen InactivatorsIBA 04/2022
1	heparanaseIBA 05/2021
1	AdipokinesIBA 06/2020
1	asialo-von Willebrand FactorIBA 01/2020
1	PlasminogenIBA 07/2013
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 07/2010

3	Therapeutics 03/2024 - 07/2013
2	Drug Therapy (Chemotherapy) 04/2023 - 09/2019
2	Radiotherapy 04/2023 - 09/2019
1	Brachytherapy 03/2024
1	Immunotherapy 04/2023
1	Adjuvant Chemotherapy 04/2023
1	Surgical Amputation (Amputations) 04/2015
1	Segmental Mastectomy (Lumpectomy) 04/2015